PITX1 Is a Reliable Biomarker for Predicting Prognosis in Patients With Oral Epithelial Dysplasia

Oncology Letters - Greece
doi 10.3892/ol.2013.1775
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

KPNA2 Is a Potential Diagnostic Serum Biomarker for Epithelial Ovarian Cancer and Correlates With Poor Prognosis

Tumor Biology
MedicineCancer Research
2017English

Glucosylsphingosine Is a Reliable Response Biomarker in Gaucher Disease

American Journal of Hematology
Hematology
2018English

SCCA2 Is a Reliable Biomarker for Evaluating Pediatric Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Malignant Transformation Rate in Patients Presenting Oral Epithelial Dysplasia: Systematic Review and Meta-Analysis

Journal of Oral Diseases
2015English

Inflammatory Biomarkers Predicting Prognosis in Patients With Acute Dyspnea

American Journal of Emergency Medicine
MedicineEmergency Medicine
2016English

Circulating Tumour Cell-Derived Plastin3 Is a Novel Marker for Predicting Long-Term Prognosis in Patients With Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Hematinic Deficiency and the Risk of Oral Epithelial Dysplasia

Mouth and Teeth
2017English

RIG-I Expression in Perifascicular Myofibers Is a Reliable Biomarker of Dermatomyositis

Arthritis Research & Therapy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy